Triplet Delays Breast Cancer Progression in First-Line Maintenance Setting

(MedPage Today) — SAN ANTONIO — Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab and pertuzumab (Perjeta) significantly improved progression-free survival (PFS) in patients with HER2-positive metastatic breast cancer…

Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/118958

Author :

Publish date : 2025-12-11 17:19:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Triplet Delays Breast Cancer Progression in First-Line Maintenance Setting

Wes Streeting confirms public inquiry into Teesside NHS trust

Disney and OpenAI have made a surprise deal – what happens next?

Related Posts

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

Topical Calcineurin Inhibitors Show No Lymphoma Signal

More Pain at Discharge Tied to Higher Chances of Readmission

Families with children battling cancer to have travel costs covered

Older Folks Can Be Spared From Extended Surgery for Aortic Dissections

GLP-1 Pill Cut Heart Failure Events in Some Diabetes Patients

GLP-1s Linked to Reduced Bleeding in Intracranial Aneurysms

Topical Calcineurin Inhibitors Show No Lymphoma Signal

More Pain at Discharge Tied to Higher Chances of Readmission

Families with children battling cancer to have travel costs covered

Older Folks Can Be Spared From Extended Surgery for Aortic Dissections

GLP-1 Pill Cut Heart Failure Events in Some Diabetes Patients

Hypertension Control Still Eludes Most in the U.S.

HHS Unveils Program to Address Homelessness and Addiction

Categories

Archives